Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 69Other hematologic neoplasm 31Sarcoma 11CNS 11Other solid neoplasm 5Myeloid 3Genitourinary 3Gastrointestinal 1Dermatologic 1

Conditions

Hepatoblastoma 1

Interventions

Oxaliplatin 197Bevacizumab 164Fluorouracil 153Gemcitabine 137Capecitabine 137Leucovorin 110pembrolizumab 102Cisplatin 98Drug Therapy 90Irinotecan 79Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 68durvalumab 67Paclitaxel 65Cetuximab 64Specimen Handling 62tislelizumab 60lenvatinib 60Magnetic Resonance Spectroscopy 57Folfox protocol 56Nivolumab 54Blood Specimen Collection 52Biopsy 48atezolizumab 47Surgical Procedures, Operative 40Taxes 39Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Vincristine × Gastrointestinal × Clear all
NCT04478292 2026-05-04

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

Shanghai Children's Medical Center

Phase 3 Recruiting
330 enrolled
Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡